| Branden Goben, CADC-I | |
|
1755 Sullivan Ln, Sparks, NV 89431-2815 | |
| (775) 355-7734 | |
| (775) 460-4822 |
| Full Name | Branden Goben |
|---|---|
| Gender | Male |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 1755 Sullivan Ln, Sparks, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073389177 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 07536-I (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Branden Goben, CADC-I 1755 Sullivan Ln, Sparks, NV 89431-2815 Ph: (775) 355-7734 | Branden Goben, CADC-I 1755 Sullivan Ln, Sparks, NV 89431-2815 Ph: (775) 355-7734 |
News Archive
A modest suppression of growth hormone and related compounds beginning in early adulthood may delay the onset or progression of several types of cancer, researchers from Wake Forest University School of Medicine and other centers reported today at ENDO 2005, the annual meeting of the Endocrine Society, in San Diego.
During minimally invasive operations, a surgeon has to trust the information displayed on the screen: A virtual 3D model of the respective organ shows where a tumor is located and where sensitive vessels can be found.
A new portable system which cools the brain via the nasal cavity may improve survival following cardiac arrest compared with standard care procedures, particularly when CPR and cooling are initiated early. Results from a recent study showed that the RhinoChill(TM) Intra-Nasal Cooling System enabled brain temperature to reach target several hours earlier than patients cooled in the emergency room. It is widely recognized that the sooner brain temperature can be reduced, the better the chances of minimizing long-term damage.
UC San Francisco will receive $4.5 million over the next five years for a pilot project to assess whether large-scale gene sequencing aimed at detecting disorders and conditions can and should become a routine part of newborn testing.
Alcon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved PATANASE(R) (olopatadine hydrochloride) nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older.
› Verified 3 days ago
Alicia Aparicio, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1795 Trabert Cir, Sparks, NV 89431 Phone: 775-636-1277 | |
Carresa Greer, Counselor Medicare: Not Enrolled in Medicare Practice Location: 390 Freeport Blvd #3, Sparks, NV 89431 Phone: 775-378-0004 | |
Erin Fey, MS, LMFT INTERN Counselor Medicare: Not Enrolled in Medicare Practice Location: 350 Kresge Ln, Sparks, NV 89431 Phone: 775-359-9200 Fax: 775-359-9205 | |
Sucelly Melissa Diaz Erazo, Counselor Medicare: Not Enrolled in Medicare Practice Location: 501 El Rancho Dr Spc 88, Sparks, NV 89431 Phone: 775-223-6530 | |
Courtney Mckenna, Counselor Medicare: Not Enrolled in Medicare Practice Location: 480 Galletti Way, Sparks, NV 89431 Phone: 775-688-1633 | |
Paula Lopez, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 480 Galletti Way, Sparks, NV 89431 Phone: 775-688-0423 Fax: 775-688-2081 | |
Dana Skylar Gray, LSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 480 Galletti Way Bldg 8n, Sparks, NV 89431 Phone: 775-688-1633 |